RELATED CONTENT
NEWS
- US high court allows securities fraud lawsuit over Merck & Co's Vioxx
- US high court allows securities fraud lawsuit over Pfizer's Celebrex
- Merck & Co alters safety monitoring and pays lawyer fees to end US Vioxx suits
- Merck & Co may pay $80 million to settle more Vioxx claims


